I see CjsfromNSW and Lies@damnlies as both being correct in the timeframes they are considering for TFC investment.
for Lies....there is no +ve surprise emerging from this result. So a repeat of the short squeeze seen this time last year is not being repeated, and the downwards share price trend seen thus far in CY2017 may continue until we hit support closer to the $1.40 level.
for Cjs....full year guidance confirmed, another harvest validating Sandalwood growing, all those underlying long-term factors remain intact. Keep TFC in a firmly locked bottom drawer.
Looks like we have a confirmation of likely declining profit in FY18 due to lower harvests.
I am a little surprised by mgt talk of a Santalis divestment. It could generate a potential massive windfall profit in the next few years if comparables from that JP Morgan Healthcare conference presentation are anywhere close to being correct, but does seem to go against the strategic rationales discussed back in 2015 regards vertical integration.
TFC Price at posting:
$1.50 Sentiment: Hold Disclosure: Held